Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aggressive Variant Prostate Carcinoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Looking for participantsNCT05563558
What this trial is testing

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Who this might be right for
Prostate Cancer Metastatic
Fundacion Oncosur 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03263650
What this trial is testing

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Who this might be right for
Prostate Cancer AggressivenessProstate Carcinoma
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00514540
What this trial is testing

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 121
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218666
What this trial is testing

Zanzalintinib in Men With Aggressive Variant Prostate Cancer

Who this might be right for
Aggressive Variant Prostate Carcinoma
Deepak Kilari 30
Testing effectiveness (Phase 2)Study completedNCT05005728
What this trial is testing

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04709276
What this trial is testing

Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Cancer
Andrew J. Armstrong, MD 41
Large-scale testing (Phase 3)Looking for participantsNCT06470243
What this trial is testing

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network 528
Testing effectiveness (Phase 2)Looking for participantsNCT07179783
What this trial is testing

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06085729
What this trial is testing

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 30